• Tchaikapharma’s new atithrombotic drug receives marketing authorization

    February 16, 2024

    Tchaikapharma has received marketing authorization for a new medicinal product:


    Telmira 60 mg film-coated tablets
    Telmira 90 mg film-coated tablets


    Telmira contains a medicinal substance called ticagrelor. It belongs to a group of medicines called antithrombotic medicines.


    Telmira, given at the same time as acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with:


    – acute coronary syndrome (ACS) or

    – a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event.


    The medicinal product is available on prescription.
    ATC code: B01AC24